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ABSTRACT 
Unsupervised clustering has broad applications in data stratification, pattern investigation and new dis-
covery beyond existing knowledge. In particular, clustering of bioactive molecules facilitates chemical 
space mapping, structure-activity studies, and drug discovery. These tasks, conventionally conducted by 
similarity-based methods, are complicated by data complexity and diversity. We explored the superior 
learning capability of deep autoencoders for unsupervised clustering of 1.39 million bioactive molecules 
into band-clusters in a 3-dimensional latent chemical space. These band-clusters, displayed by a space-
navigation simulation software, band molecules of selected bioactivity classes into individual band-
clusters possessing unique sets of common sub-structural features beyond structural similarity. These 
sub-structural features form the frameworks of the literature-reported pharmacophores and privileged 
fragments. Within each band-cluster, molecules are further banded into selected sub-regions with re-
spect to their bioactivity target, sub-structural features and molecular scaffolds. Our method is potential-
ly applicable for big data clustering tasks of different fields. 
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Unsupervised data clustering has found extensive applications in various data stratification, pattern cat-
egorization, and knowledge discovery tasks beyond existing knowledge(1). An outstanding problem is 
the clustering of big data beyond conventional similarity-based approaches (2-5). Specifically, unsuper-
vised clustering of bioactive molecules with respect to their common molecular determinants(6-10) fa-
cilitates the mapping of bioactive or pharmacological chemical space, the investigation of structure-
activity relationships, and drug discovery(10, 11). Several similarity-based methods have been em-
ployed for unsupervised grouping of molecules by hierarchical clustering of the molecular scaffolds(6) 
and substructure fingerprints(9), and by matching molecular fragments(7, 12), substructures(8, 12) and 
physicochemical properties(10). These methods employ the similarity principle for clustering molecules 
under the conventional molecular representations (molecular scaffolds, fragments, substructure finger-
prints, and physicochemical properties). However, not all complex features of bioactivities are captura-
ble by similarity-based analysis within conventional molecular frameworks. A new approach is needed 
for clustering molecules and other big data beyond the conventional algorithms and data representations. 
A potentially-useful approach for unsupervised clustering beyond the conventional algorithms and rep-
resentations is deep neural networks (DNNs). DNNs have been employed for unsupervised learning of 
the informative features by its unique ability to flatter the complex data(13) and segment them into clas-
ses of specific characteristics(14) while preserving the local and global data characteristics(15). The 
DNN-learned informative features have been used as pre-trained representation features of the conven-
tional machine learning methods for improved data clustering(16) and classification(17). DNNs trained 
on 4.9-50 million samples have successfully accomplished difficult tasks(18, 19). These distinguished 
capabilities of DNNs in learning complex features from big data may be explored for unsupervised clus-
tering of big data beyond the conventional frameworks.  
DNN-learned informative features has been presented or projected to 2-dimensional latent space for re-
vealing the data landscapes in that space(20-22). In some cases, the DNN-learned features in the 2-
dimensional latent space present a landscape of band-clusters (data distributed into bands of particle 
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streams), with each band-cluster grouping together subsets of the data of common frameworks but vary-
ing global features (e.g. images of a handwritten digit, Reuter newswire stories of a topic such as energy 
markets, and drug-like molecules of similar logP values)(20, 21, 23).  
Hence, DNNs may have the ability to group data into band-clusters of common frameworks beyond 
similarity and conventional data representations. A question is whether this ability may be exploited for 
unsupervised clustering of structurally-diverse bioactive molecules into band-clusters of molecules of 
selected bioactivities with unique elements of pharmacophores(24), privileged substructures(25-27), and 
scaffold branches(11). Although the band-cluster characteristics are contained in the DNN-learned fea-
tures, feeding these features into a conventional clustering method(16) subject them to the limitations of 
the similarity framework. Projection of the DNN-learned features to 2-dimentional space(20-22) lead to 
information loss in low-dimensionality and in some cases subject to the limitations of the dimensionali-
ty-reduction methods (e.g. PCA and t-SNE). 
One alternative approach to alleviate these problems is to employ DNNs to directly learn informative 
features in a 3-dimentional latent space, wherein the DNN-generated band-clusters are subject to less 
information-loss than in 2-dimensional latent space, and the landscapes can be straightforwardly dis-
played and analyzed by a space-navigation simulation software without using a dimensionality-
reduction method. A critical question is whether the DNN-learned features in 3-dimentional latent space 
can adequately indicate the band-clusters of common frameworks. This question was interrogated by 
analyzing the members of individual band-cluster with respect to their bioactivity-classes (e.g. kinase 
inhibitors) and the common sub-structural features with respect to the literature-reported pharmaco-
phores(28) and privileged substructures(25, 26) of the bioactivity classes in the band-cluster. 
We developed the deep autoencoders (DAEs) for unsupervised clustering of 1.39 million ChEMBL bio-
active molecules(29) in a 3-dimensional latent chemical space, together with a chemical space naviga-
tion simulation software DeepChemScape for displaying and analyzing the band-cluster landscapes. The 
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molecules of individual band-cluster were extracted by density analysis or by reference to the manually-
selected molecules that visibly define band-cluster boundaries. The intra-cluster molecules of two se-
lected band-clusters were analyzed for their bioactivity profiles and common sub-structural features in 
comparison with the literature-reported pharmacophores(28) and privileged structures(25, 26) of the bi-
oactivities enriched in these band-clusters.  
Data collection, processing and molecular representation  
The SMILES structures, macromolecule targets and the activity values (in IC50, EC50, and Ki) of 1.7 
million bioactive molecules were from the ChEMBL database version-22(29). The SMILES structures 
were processed by using Open Babel(30) to convert them into the MOL 2D format, remove single-atom 
structures and salts, discard the smaller independent structures, and add explicit hydrogens. There are 
386,655 molecules active against 2,245 targets with IC50, EC50, or Ki <10 μM, a widely-used bioactiv-
ity cut-off(31). These 2,245 targets were mapped to 30 level-2 ChEMBL target families(29) (Supple-
mentary Table S1), 1,398 Pfam domain families, or 2,251 Interpro domain families via CheMBL cross-
links to the corresponding Uniprot and Interpro entries. There are 1,011,600 additional molecules with 
lower activities (IC50, EC50, or Ki >10 μM), ambiguous activity values (e.g. % inhibition at one con-
centration), or un-defined targets (e.g. cell-lines). These molecules of low or unspecified activities were 
used for training the DAE models. 
In chemical space mapping(11), visualization(32) and virtual screening(33), molecules have been fre-
quently represented by molecular fingerprints(9, 33) that encode molecular structures by a series of bi-
nary digits indicating the presence or absence of individual substructures(9, 33). Specifically, we used 
Padel(34) to compute the 881-bit Pubchem fingerprints for 1,623,663 molecules. These molecules were 
further divided into two sets: Version-19 set (1,398,255 molecules) and the new-additions set (225,408 
molecules added after Version 19) for training and validating the DAE models. 
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Unsupervised clustering and display of molecules in a 3-dimensional latent chemical space with 
deep autoencoder networks  
Our DAEs are composed of a pair of complementary DNNs. An auto-encoder converts molecular fin-
gerprints into 3-imensional latent codes for data clustering. An auto-decoder converts the latent codes 
back to the original molecular fingerprints for optimizing the auto-encoder. The auto-encoder was 
trained and tested on 4/5 and 1/5 randomly selected molecules of the Version-19 set, and validated on 
the new-additions set. The optimization of the DAE hyperparameters was conducted in two phases as 
described in Supplementary Methods, which proceeds until the reconstruction rate reaches optimal val-
ue and the molecules are distributed in band-clusters(20, 21, 35) in the 3-dimensional latent chemical 
space as revealed by a chemical space navigation software DeepChemScape (Supplementary Methods).  
The band-clusters of 1.39 million bioactive molecules in 3-dimensional latent chemical space and 
the banded distributions of bioactivity classes 
Figure 1 shows the DAE-learned band-cluster landscape of the 1.39 million Chembl bioactive molecules 
in the 3-dimentional latent chemical space displayed on DeepChemScape. Molecules are represented as 
individual spheres in default grey colors except those in 10 selected band-clusters highlighted by other 
colors. Consistent with the literature-reported DNN-learned landscapes of various data-types in two-
dimensional latent space(20, 21, 23), all molecules are aligned into band-clusters confined within a vast 
cone-shaped subspace. Band-clusters roughly originate from a common central region (center of the bi-
oactive universe) and extend outwardly like straight particle streams. Many band-clusters are populated 
by the moderate-to-high (<10μM) potency molecules of selected bioactivity classes. Inspection of the 
ChEMBL level-2 target families(29) of these molecules revealed that each band-cluster typically groups 
together molecules of selected bioactivity classes. Figure 2 shows three band-clusters A, B and C with 
different bioactivity classes highlighted by different colors. The structure, target and molecular scaffolds 
of all molecules in band-cluster A and B are provided in Supplementary Table S2 and S3 respectively.  
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Band-cluster A (6121 molecules) is primarily composed of 67.55% molecules of low or unspecified ac-
tivities, 10.50% family-A GPCR ligands, 8.66% kinase inhibitors, 2.6% nuclear receptor ligands, 2.5% 
protease inhibitors, 1.88% reader, 1.39% family-B GPCR ligands and 1.14% eraser inhibitors. Band-
cluster B (3410 molecules) consists of 67.62% molecules of low or unspecified activities, 15.95% fami-
ly-A GPCR ligands, 6.48% protease inhibitors, 2.35% voltage-gated ion channel blockers, 1.79% reader 
inhibitors, 1.23% kinase inhibitors and 1.2% nuclear receptor ligands. Band-cluster C (8820 molecules) 
contains 69.17% molecules of low or unspecified activities, 15.73% protease inhibitors, 6.09% family-A 
GPCR ligands, 2% reader inhibitors, 1.98% nuclear receptor ligands, 1.34% ion channel ligands, and 
0.92% cytochrome P450 inhibitors. Within each band-cluster, molecules of the same bioactivity class 
are concentrated in several separated sub-regions. For instance, kinase inhibitors, GPCR ligands, and 
protease inhibitors in band-cluster A, B, and C are primarily in 9, 8 and 6 sub-regions respectively. Such 
banded distribution patterns were also found when molecules were inspected by Pfam or Interpro do-
main families. 
Unique combinations of sub-structural features and distinguished molecular scaffolds of individu-
al band-cluster 
The concentrated distribution of selected bioactivity classes in individual band-clusters raises a question 
about what common sub-structural features are captured by the DAEs. Structural analysis of the mole-
cules in several band-clusters showed that each band-cluster consists of molecules of unique combina-
tions of sub-structural features. These involve combinations of three sub-structural elements (core hy-
drogen bond, core hydrophobic ring, linker between core elements) or minor structural variations of 
these elements. Figure 3 shows several representative molecules in band-cluster A, with their common 
sub-structural features highlighted by red (core hydrogen-bond element), blue (core hydrophobic ring 
element) and green (linker between core elements) colors. Supplementary Figure S2 and S3 show 298 
and 295 molecules of band-cluster A and B respectively, with their common sub-structural features 
highlighted by the same color scheme. 
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In band-cluster A, the core hydrogen-bond element is of two framework groups. One is the Y-shaped N-
N-N, N-O-N, N-S-N and O-N-O frameworks and their structural variations N-N-CN, N-N-CCN, N-N-
C, N-O-CN, N-O-C, N-S-CN, and O-N-CO. Another is the line-shaped NC-N-CN framework and their 
structural variations NC-N-C, NC-N-CS, and NC-N-CCN. Multiple frameworks appear in a band-
cluster because DAE-learned features are derived from weighted contributions of multiple sub-
structures encoded in the Pubchem molecular fingerprints. These sub-structures and their variations may 
accord higher weight of importance and were subsequently captured by DAEs. The core hydrophobic 
ring element is of two frameworks, 6-member and 5-member carbon rings, plus different 1-heteroatom 
variations. Additional variations of these rings include 7-member carbon ring, multi-carbon single chain, 
and branched pair of short carbon chains or methyl-groups, which may contribute comparable hydro-
phobic interactions as a 6-member or 5-member carbon ring. The linker element is 1- to 4- carbon-bond 
chain.  
In band-cluster B, the core hydrogen-bond element is of V-shaped NCN, NCO, OCO, SCS frameworks 
and their structural variations NCCN, NCC, NNCO, NCCO, and OCC. The core hydrophobic ring ele-
ment is of the 6-member and 5-member ring frameworks, with each ring containing two-neighbor nitro-
gen heteroatoms (RNN), two non-neighbor nitrogen heteroatoms (RN2), 1-nitrogen heteroatom (RN), or 
all carbon atoms (R). The linker element is 1- to 4- carbon-bond chain connecting two core elements. 
Analysis of these and other band-clusters revealed that each band-cluster captures unique combinations 
of sub-structural elements fairly common within a band-cluster but largely distinguished among differ-
ent band-clusters, consistent with the banding of different handwritten digits or different topics of Reu-
ter newswire stories into different band-clusters (20, 21). While its members are characterized by unique 
combinations of the sub-structural features, each band-cluster primarily groups together molecules of 
diverse scaffolds or sub-structures with fewer overlaps with the scaffolds of other band-clusters. For in-
stance, band-cluster A and B contain 37 and 99 molecular scaffolds respectively (Supplementary Table 
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S4), only six molecular scaffolds were found in both band-clusters (indoles, benzenoids, biphenyls, in-
dolines, amino acids and pyrimidines). 
Relevance and distinction of DAE-captured sub-structural features with respect to the literature-
reported pharmacophores and privileged structures.  
A question may be raised about the relevance of the DAE-captured sub-structural features to the select-
ed bioactivities of the band-cluster. This question was probed by comparing the sub-structural features 
of band-cluster A (8.66% members are kinase inhibitors) with the literature-reported pharmacophores 
and privileged structures of kinase inhibitors(26, 28, 36), and the sub-structural features of band-cluster 
B (15.95% members are GPCR ligands) with the literature-reported privileged structures of GPCR lig-
ands(37). Some sub-structural features of band-cluster A form the key frameworks of the literature-
reported kinase-binding modes of kinase inhibitor drugs(28), pharmacophores of kinase frequent hit-
ters(36) and privileged fragments of kinase inhibitors(26) (Figure 4 and Supplementary Figure S3). Spe-
cifically, these are the combinations of a core hydrogen-bond element (Y-shaped N-N-N, N-N-CN, N-S-
N, N-O-C or L-shaped NC-N-CN, N-N-CN) and a core hydrophobic ring element. Some sub-structural 
features of band-cluster B also form the key frameworks of most of the literature-reported GPCR privi-
leged structures(37) (Supplementary Figure S4). These are the combinations of a core hydrogen-bond 
element (V-shaped NCO, NCN, NCCO) and a core hydrophobic ring element (R and RN).  
The connection of the DAE-captured sub-structural features to the frameworks of the selected bioactivi-
ties and the concentration of molecules of these bioactivities in a band-cluster is consistent with the re-
ports that the kinase privileged fragments provide ~5-fold enrichment in kinase inhibitors (26). It is also 
consistent with the reports that some privileged molecular scaffolds enable activities against multiple 
target classes(25, 38). Nonetheless, the DAE-captured sub-structural elements differ from the literature-
reported pharmacophores and privileged fragments in one aspect. DAEs capture the fundamental sub-
structural elements and their structural variations whose combinations define the frameworks of the 
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pharmacophores or privileged fragments. In contrast, the literature-reported kinase privileged structures 
are specific fragments such as the bisaryl-NH- linker fragments(26) and the bisphenylether scaf-
folds(38). Therefore, by learning the fundamental elements of structural frameworks, DAEs capture 
more variety of pharmacophores and privileged structures within individual band-cluster. 
Intra band-cluster distribution of bioactivity targets 
Given the banding of molecules of the selected bioactivity classes into selected band-clusters, a question 
arises about whether the molecules of specific target are further banded into selected sub-regions within 
a band-cluster. We analyzed the targets of the kinase inhibitors in band-cluster A (Supplementary Table 
S2) and the targets of the GPCR ligands in band-cluster B (Supplementary Table S3). While the mole-
cules of the same target may be across multiple sub-regions, they tend to be banded in 1-3 selected sub-
regions. In band-cluster A, the nine sub-regions populated by kinase inhibitors (Figure 2) are labeled as 
A1 to A9 from nearer the center of bioactive universe to the outward direction along the band-cluster. In 
A1, 9 of the 10 kinase inhibitors target MAPKAPK2. In A2, 15, 15, 14, 11, 11, 10, 9, 9 and 9 of the 80 
kinase inhibitors (including multi-target inhibitors) target PDGFR , VEGFR2, P38 , MAP2K1, EGFR 
PLK3, CLK4, FGFR1, and CDK2 respectively. In A3, 17 and 14 of the 89 kinase inhibitors target 
EGFR and CDK1. In A6, 17, 16 and 10 of the 30 kinase inhibitors target CDK1, GSK-3 and CDK5. 
In A7, 15 and 9 of the 25 kinase inhibitors target AkT2 and PDPK1. In A8, 53, 34, 34, 22, 19,17, 16 and 
16 of the 225 kinase inhibitors target VEGFR2, CDC7, PDGFR, ALK, KIT, Chk1, MAPKAPK2, and 
RET respectively. In A9, 26, 16, and 16 of the 49 kinase inhibitors target PKC, PKA, and EGFR.  
Intra band-cluster distribution of sub-structural features and molecular scaffolds 
In addition to the banding of the molecules of specific target into selected sub-regions of a band-cluster, 
the DAE-captured sub-structural features and molecular scaffolds in a band-cluster are also banded into 
selected sub-regions. For instance, band-cluster A starts near the center of bioactive universe with sub-
regions of higher concentrations of the Y-shaped N-S-N and N-S-CN frameworks. Going further out-
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ward along the band-cluster are sub-regions of higher concentrations of the line-shaped NC-N-CN, NC-
N-CCN, NC-N-C, NC-N-CS frameworks and Y-shaped N-N-N, N-N-CN, N-N-CCN, N-N-C frame-
works. Going toward the outer-edge are sub-regions of higher concentrations of the Y-shaped N-O-N, 
O-N-O, N-O-CN, N-O-C, and O-N-CO frameworks. Band-cluster B starts near the center of bioactive 
universe with sub-regions of higher concentrations of the RNN frameworks. Going outward along the 
band-cluster are sub-regions of higher concentrations of the RN2 and RN3 frameworks, followed by the 
sub-regions of higher concentrations of the R frames near the outer-edge. 
The molecular scaffolds in sub-cluster A are also banded. A1 is enriched with N-phenylthioureas (8 
molecules). A2 is populated by diazines, pyrimidines, diazanaphthalenes, thienopyrimidines, quinazo-
linamines, and benzodiazines (14, 14, 12, 12, 12 and 12 molecules). A3 is populated by benzimidazoles, 
diazanaphthalenes, benzodiazines, imidazopyridines and pyrimidines (11, 8, 8, 6, and 6 molecules). A6 
is enriched with benzazepines and indoles (7 and 4 molecules). A7 is enriched with benzenoids, N-
phenylureas and indolines (6, 5, and 3 molecules).  A8 is populated by indoles, indolines, amino acids, 
pyrroles, carbazoles, pyrrolopyridines, and pyrrolocarbazoles (72, 34, 28, 24, 19, 15 and 13 molecules). 
A9 is populated by pyrrolocarbazoles, carbazoles, indolocarbazoles, and indoles (10 molecules each). A 
similar pattern of banded distribution of the molecular scaffolds were also found in band-cluster B. 
Concluding remarks 
DAEs showed superior capability in unsupervised clustering of big data into band-clusters of unique 
combinations of sub-component features but varying global features beyond data similarity. The deep 
learned combinations of sub-component features represent functionally or architecturally important in-
trinsic properties of the data in a band-cluster distinguished from other band-clusters. Analysis of the 
DAE-captured band-clusters of 1.39 million bioactive molecules showed that individual band-cluster 
groups together selected classes of bioactive molecules, whose structures are commonly composed of 
unique combinations of sub-structural features. These sub-structural features form the frameworks of 
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the literature-reported pharmacophores and privileged fragments distinguished from other band-clusters. 
DAEs further band the molecules in a band-cluster into selected sub-regions enriched with higher con-
centration of the same bioactivity target and distinguished sets of molecular scaffolds.  
These distinguished features of DAE-derived band-clusters are useful for grouping big data into func-
tionally or architecturally relevant groups (clusters) and sub-groups (sun-regions). Our method may find 
extensive applications in big data clustering, stratification and knowledge discovery tasks in drug dis-
covery(2), healthcare(3), biomedicine(4), biology(5), astronomy(39), economics(40) and other fields. 
Our method is based on the deep feature learning in a 3-dimensional latent space followed by visualiza-
tion-facilitated analysis of data band-clusters. Although DAEs are capable of clustering big data into 
functionally and architecturally relevant groups and sub-groups, the learning in a 3-dimensioanl latent 
space instead of the usual higher dimensional latent space likely results in some degree of information 
loss, which may affect the quality and purity of the band-clusters and their sub-regions, as indicated by 
the scattered distribution of molecules of various bioactivity classes in individual band-clusters. Further 
efforts are needed for the development of bind-cluster extraction and evaluation methods in higher-
dimensional latent space. 
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FIGURE LEGENDS 
Figure 1. The band-cluster landscapes of 1.39 million Chembl bioactive molecules in the DAE-captured 
3-dimentional latent chemical space, displayed on DeepChemscape. Top view: molecules are represent-
ed by individual spheres in default grey color, except 10 band-clusters highlighted by other colors. Two, 
five and three of these 10 band-clusters are populated by kinase inhibitors (blue, lime), GPCR ligands 
(beige, fuchsia, pink, teal, purple), and protease inhibitors (green, yellow). The red band-cluster is dom-
inated by molecules of unspecified bioactivity. Bottom view: 10 colored band-clusters alone. 
Figure 2. Three band-clusters populated by molecules of selected bioactive classes. The top, middle and 
bottom band-cluster A, B, and C populated by kinase inhibitors (blue), GPCR ligands (orange), and pro-
tease inhibitors (green) respectively. The other bioactivity classes with significant populations are nucle-
ar receptor ligands (purple) and voltage-gated ion channel inhibitors (pink).The center of bioactive uni-
verse is at the left bottom corner of each sub-figure. 
Figure 3. The structures of the selected molecules of band-cluster A in Figure 2. Their common sub-
structural features highlighted by red (core hydrogen-bond element), blue (core hydrophobic ring ele-
ment) and green (linker between core elements) colors. 
Figure 4. The key pharmacophoric elements of the binding modes of kinase inhibitor drugs reported in 
literature. The core pharmacophoric elements highlighted by red (core hydrogen-bond element), blue 
(core hydrophobic ring element) and green (linker between core elements) colors. 
 
 
 
 
 
